@FierceBiotech: NGM raises $13M for cardio/metabolic R&D work. Item | Follow @FierceBiotech
@JohnCFierce: Astellas, VCs stake virtual biotech spinout with $15M and a PhII program. Release | Follow @JohnCFierce
@RyanMFierce: Pfizer opts to keep running Accelrys software in its labs. Article | Follow @RyanMFierce
> Portola Pharmaceuticals has set a range of $13 to $16 a share for the 6.9 million shares it plans to sell in a $100 million IPO. Report
> The Seattle-based Accelerator Corp., which finances and launches biotech companies, has plans to open up a second location in New York. Story
> Quintiles spinoff NovaQuest Capital has raised an additional $80 million from investors. The finance group invests in late-stage and commercial assets. Report
> GW Pharma has won approval for Sativex in Italy. Story
> Sanofi Canada officially opened a new headquarters in Laval, Quebec, where the company has operated since 1968. Article
@FierceMedDev: Hologic slashes outlook as losses widen. Report | Follow @FierceMedDev
@MarkHFierce: Dx test maker Quidel now owns BioHelix, for $10M, plus milestone payments. Item | Follow @MarkHFierce
@DamianFierce: Medtronic won FDA approval for two new cardiac devices. Story | Follow @DamianFierce
> Mindray soars in Q1 with 21% Dx growth. Report
> Mass General repurposes cancer Dx tool for multiple use. DxExtra
Pharma News
@FiercePharma: Lilly salesforce cuts to be deeper than expected, Indy Biz Journal says: 1,624 jobs, or 40%, not 30%. Report | Follow @FiercePharma
@EricPFierce: Eli Lilly's CEO John C. Lechleiter will have surgery and be out for some weeks. Release | Follow @EricPFierce
> Don't confuse Kadcyla with Herceptin, FDA says. More
> Lilly CEO set for surgery on dilated aorta; CFO steps up temporarily. Article
> DEA finally acts on Belviq, clearing Arena for diet drug's launch. Article
Pharma Manufacturing News
> Pfizer sells Viagra online to take away play by counterfeiters. Item
> Novo investing $67M in Denmark plant. Article
> J&J dealing with OTC manufacturing issues on 3 continents. Story
> Sagent buys full control of China plant. News
Biotech Research News
@EmilyMFierce: New molecule could be potential therapy for muscular dystrophy. More | Follow @EmilyMFierce
> Inhibiting a protein could provide new avenue for antidepressant drug development. Report
> Genetic 'switch' could halt aggressive cancer growth. More
> Scientists create more accurate animal model of Type 2 diabetes. Story
> Mayo Clinic develops drug that stops growth of kidney cancer. Article
And Finally… A new survey finds that the top 25 pharma companies in India spend an average of only 6% to 7% of total sales on R&D. Story